Why you should do Impurities Analyses Early in Pharmaceutical Research and Discovery?
Why you should do Impurities Analyses Early in Pharmaceutical Research and Discovery? March 26, 2019 Major impurities in a drug product should ideally be identified in the early stage of the drug development process, to achieve better control of manufacturing (CMC) in the later stages of compound development. However, those present only at low concentrations …
Why you should do Impurities Analyses Early in Pharmaceutical Research and Discovery? Read More »